BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kiska DL, Thiede B, Caracciolo J, Jordan M, Johnson D, Kaplan EL, Gruninger RP, Lohr JA, Gilligan PH, Denny FW Jr. Invasive group A streptococcal infections in North Carolina: epidemiology, clinical features, and genetic and serotype analysis of causative organisms. J Infect Dis 1997;176:992-1000. [PMID: 9333158 DOI: 10.1086/516540] [Cited by in Crossref: 88] [Cited by in F6Publishing: 76] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Traverso F, Blanco A, Villalón P, Beratz N, Sáez Nieto JA, Lopardo H; National Collaborative Group for the Study of Streptococci and Related Bacteria. Molecular characterization of invasive Streptococcus dysgalactiae subsp. equisimilis. Multicenter study: Argentina 2011-2012. Rev Argent Microbiol 2016;48:279-89. [PMID: 28341023 DOI: 10.1016/j.ram.2016.07.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
2 Kawabata S, Kuwata H, Nakagawa I, Morimatsu S, Sano K, Hamada S. Capsular hyaluronic acid of Group A Streptococci hampers their invasion into human pharyngeal epithelial cells. Microbial Pathogenesis 1999;27:71-80. [DOI: 10.1006/mpat.1999.0283] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 1.5] [Reference Citation Analysis]
3 Gibbon, Bewley. Acquired streptococcal necrotizing fasciitis following excision of malignant melanoma: NECROTIZING FASCIITIS FOLLOWING MALIGNANT MELANOMA. British Journal of Dermatology 1999;141:717-9. [DOI: 10.1046/j.1365-2133.1999.03117.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
4 May AK, Stafford RE, Bulger EM, Heffernan D, Guillamondegui O, Bochicchio G, Eachempati SR. Treatment of Complicated Skin and Soft Tissue Infections. Surgical Infections 2009;10:467-99. [DOI: 10.1089/sur.2009.012] [Cited by in Crossref: 98] [Cited by in F6Publishing: 84] [Article Influence: 7.5] [Reference Citation Analysis]
5 Duff BA, Denny FW, Kiska DL, Lohr JA. Invasive Group A Streptococcal Disease in Children. Clin Pediatr (Phila) 1999;38:417-23. [DOI: 10.1177/000992289903800708] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
6 Factor SH, Levine OS, Harrison LH, Farley MM, McGeer A, Skoff T, Wright C, Schwartz B, Schuchat A. Risk factors for pediatric invasive group A streptococcal disease. Emerg Infect Dis 2005;11:1062-6. [PMID: 16022781 DOI: 10.3201/eid1107.040900] [Cited by in Crossref: 48] [Cited by in F6Publishing: 38] [Article Influence: 2.8] [Reference Citation Analysis]
7 Harris P, Siew D, Proud M, Buettner P, Norton R. Bacteraemia caused by beta-haemolytic streptococci in North Queensland: changing trends over a 14-year period. Clinical Microbiology and Infection 2011;17:1216-22. [DOI: 10.1111/j.1469-0691.2010.03427.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
8 File TM, Tan JS. Group a streptococcus necrotizing fasciitis. Compr Ther 2000;26:73-81. [DOI: 10.1007/s12019-000-0015-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
9 Hasin O, Hazan G, Rokney A, Dayan R, Sagi O, Ben-shimol S, Greenberg D, Danino D. Invasive Group A Streptococcus Infection in Children in Southern Israel Before and After the Introduction of Varicella Vaccine. Journal of the Pediatric Infectious Diseases Society 2020;9:236-9. [DOI: 10.1093/jpids/piz013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Ibrahim LA, Sellick JA, Watson EL, McCabe LM, Schoenhals KA, Martinello RA, Lesse AJ. An Outbreak of Severe Group A Streptococcus Infections Associated with Podiatric Application of a Biologic Dermal Substitute. Infect Control Hosp Epidemiol 2016;37:306-12. [PMID: 26673775 DOI: 10.1017/ice.2015.306] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
11 Svensson N, Oberg S, Henriques B, Holm S, Källenius G, Romanus V, Giesecke J. Invasive group A streptococcal infections in Sweden in 1994 and 1995: epidemiology and clinical spectrum. Scand J Infect Dis 2000;32:609-14. [PMID: 11200369 DOI: 10.1080/003655400459504] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 1.5] [Reference Citation Analysis]
12 Bosch T, Riera M, Galmés M, Ramírez A, Albertí S. [Invassive infections caused by Group A streptococci: clinical characteristics and microbiological analyses in 31 cases]. Enferm Infecc Microbiol Clin 2001;19:371-5. [PMID: 11602138 DOI: 10.1016/s0213-005x(01)72669-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
13 Italiano CM, Toi CS, Chan SP, Dwyer DE. Prolonged varicella viraemia and streptococcal toxic shock syndrome following varicella vaccination of a health care worker. Med J Aust 2009;190:451-3. [PMID: 19374621 DOI: 10.5694/j.1326-5377.2009.tb02498.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
14 Cazorla C. De quelles données a-t-on besoin aujourd'hui pour prendre en charge les cellulites et fasciites nécrosantes? Médecine et Maladies Infectieuses 2000;30:389s-98s. [DOI: 10.1016/s0399-077x(01)80040-8] [Reference Citation Analysis]
15 Rieger UM, Gugger CY, Farhadi J, Heider I, Andresen R, Pierer G, Scheufler O. Prognostic Factors in Necrotizing Fasciitis and Myositis: Analysis of 16 Consecutive Cases at a Single Institution in Switzerland. Annals of Plastic Surgery 2007;58:523-30. [DOI: 10.1097/01.sap.0000244978.27053.08] [Cited by in Crossref: 31] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
16 Hirose Y, Shibuya H, Okazaki E, Aono K, Tokunaga A, Taguchi S, Haraguchi M, Honda H. Toxic Shock-like Syndrome with Flu-like Prodrome: aPossible Role of 'Enhancing Tissue Focus' forStreptococcal Toxic Shock. Journal of Infection 2001;42:195-200. [DOI: 10.1053/jinf.2001.0820] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
17 Okamoto S, Nagase S. Pathogenic mechanisms of invasive group A Streptococcus infections by influenza virus-group A Streptococcus superinfection: Invasive GAS infection by superinfection. Microbiol Immunol 2018;62:141-9. [DOI: 10.1111/1348-0421.12577] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
18 Pichichero ME. Pathogen shifts and changing cure rates for otitis media and tonsillopharyngitis. Clin Pediatr (Phila) 2006;45:493-502. [PMID: 16893853 DOI: 10.1177/0009922806290102] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
19 Vlaminckx B, van Pelt W, Schouls L, van Silfhout A, Elzenaar C, Mascini E, Verhoef J, Schellekens J. Epidemiological features of invasive and noninvasive group A streptococcal disease in the Netherlands, 1992-1996. Eur J Clin Microbiol Infect Dis 2004;23:434-44. [PMID: 15164257 DOI: 10.1007/s10096-004-1147-z] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 1.9] [Reference Citation Analysis]
20 Corneli HM. Rapid strep tests in the emergency department: an evidence-based approach. Pediatr Emerg Care 2001;17:272-8; quiz 279. [PMID: 11493831 DOI: 10.1097/00006565-200108000-00014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
21 Vlaminckx BJ, Mascini EM, Schellekens J, Schouls LM, Paauw A, Fluit AC, Novak R, Verhoef J, Schmitz FJ. Site-specific manifestations of invasive group a streptococcal disease: type distribution and corresponding patterns of virulence determinants. J Clin Microbiol 2003;41:4941-9. [PMID: 14605121 DOI: 10.1128/JCM.41.11.4941-4949.2003] [Cited by in Crossref: 66] [Cited by in F6Publishing: 27] [Article Influence: 3.7] [Reference Citation Analysis]
22 Murase T, Suzuki R, Osawa R, Yamai S. Characteristics of Streptococcus pyogenes serotype M1 and M3 isolates from patients in Japan from 1981 to 1997. J Clin Microbiol 1999;37:4131-4. [PMID: 10565944 DOI: 10.1128/JCM.37.12.4131-4134.1999] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
23 Dale JB. Group A streptococcal vaccines. Infect Dis Clin North Am 1999;13:227-43, viii. [PMID: 10198801 DOI: 10.1016/s0891-5520(05)70052-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
24 Gustafson LW, Blaakær J, Helmig RB. Group A streptococci infection. A systematic clinical review exemplified by cases from an obstetric department. European Journal of Obstetrics & Gynecology and Reproductive Biology 2017;215:33-40. [DOI: 10.1016/j.ejogrb.2017.05.020] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
25 Chong AH, Burrows NP. Fatal group A streptococcal necrotizing fasciitis and toxic shock syndrome in a patient with psoriasis and chronic renal impairment. Australas J Dermatol 2002;43:194-8. [PMID: 12121397 DOI: 10.1046/j.1440-0960.2002.00594.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
26 Chuang YY, Huang YC, Lin TY. Toxic shock syndrome in children: epidemiology, pathogenesis, and management. Paediatr Drugs 2005;7:11-25. [PMID: 15777108 DOI: 10.2165/00148581-200507010-00002] [Cited by in Crossref: 73] [Cited by in F6Publishing: 43] [Article Influence: 4.3] [Reference Citation Analysis]
27 Hasenboehler EA, McNair PJ, Rowland EB, Burch JM. Necrotizing streptococcal myositis of an extremity: a rare case report. J Orthop Trauma 2011;25:e23-6. [PMID: 21278607 DOI: 10.1097/BOT.0b013e3181e47fc9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
28 Lee CY, Lee YJ, Chen CC, Kuo LJ. Streptococcal toxic shock syndrome after hemorrhoidectomy: A case report. World J Clin Cases 2021; 9(33): 10238-10243 [PMID: 34904094 DOI: 10.12998/wjcc.v9.i33.10238] [Reference Citation Analysis]
29 Cue D, Southern SO, Southern PJ, Prabhakar J, Lorelli W, Smallheer JM, Mousa SA, Cleary PP. A nonpeptide integrin antagonist can inhibit epithelial cell ingestion of Streptococcus pyogenes by blocking formation of integrin alpha 5beta 1-fibronectin-M1 protein complexes. Proc Natl Acad Sci U S A 2000;97:2858-63. [PMID: 10706638 DOI: 10.1073/pnas.050587897] [Cited by in Crossref: 74] [Cited by in F6Publishing: 68] [Article Influence: 3.4] [Reference Citation Analysis]
30 Koh E, Kim S. Distribution of T types and emm Genotypes of Streptococcus pyogenes in Jinju, 2004. Ann Lab Med 2006;26:269-74. [DOI: 10.3343/kjlm.2006.26.4.269] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
31 Avanzini C, Bosio K, Volpe G, Dotti G, Savoia D. Streptococcus pyogenes Collected in Torino (Northwest Italy) Between 1983 and 1998: Survey of Macrolide Resistance and Trend of Genotype by RAPD. Microbial Drug Resistance 2000;6:289-95. [DOI: 10.1089/mdr.2000.6.289] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
32 Nakagawa I, Nakata M, Kawabata S, Hamada S. Cytochrome c-mediated caspase-9 activation triggers apoptosis in Streptococcus pyogenes-infected epithelial cells. Cell Microbiol 2001;3:395-405. [PMID: 11422082 DOI: 10.1046/j.1462-5822.2001.00122.x] [Cited by in Crossref: 66] [Cited by in F6Publishing: 64] [Article Influence: 3.1] [Reference Citation Analysis]
33 Ekelund K, Skinhøj P, Madsen J, Konradsen H. Invasive group A, B, C and G streptococcal infections in Denmark 1999–2002: epidemiological and clinical aspects. Clinical Microbiology and Infection 2005;11:569-76. [DOI: 10.1111/j.1469-0691.2005.01169.x] [Cited by in Crossref: 88] [Cited by in F6Publishing: 70] [Article Influence: 5.2] [Reference Citation Analysis]
34 Megged O, Yinnon A, Raveh D, Rudensky B, Schlesinger Y. Group A streptococcus bacteraemia: comparison of adults and children in a single medical centre. Clinical Microbiology and Infection 2006;12:156-62. [DOI: 10.1111/j.1469-0691.2005.01311.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
35 Vlaminckx BJ, Schuren FH, Montijn RC, Caspers MP, Beitsma MM, Wannet WJ, Schouls LM, Verhoef J, Jansen WT. Dynamics in prophage content of invasive and noninvasive M1 and M28 Streptococcus pyogenes isolates in The Netherlands from 1959 to 1996. Infect Immun 2007;75:3673-9. [PMID: 17452467 DOI: 10.1128/IAI.01695-06] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
36 Cox. Streptococcal necrotizing fasciitis and the dermatologist: EDITORIAL COMMENTS. British Journal of Dermatology 1999;141:613-4. [DOI: 10.1046/j.1365-2133.1999.03097.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
37 Bisno AL, Stevens DL. Streptococcus pyogenes. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Elsevier; 2010. pp. 2593-610. [DOI: 10.1016/b978-0-443-06839-3.00198-3] [Cited by in Crossref: 9] [Article Influence: 0.8] [Reference Citation Analysis]
38 Mulla ZD. Treatment options in the management of necrotising fasciitis caused by Group A Streptococcus. Expert Opin Pharmacother 2004;5:1695-700. [PMID: 15264984 DOI: 10.1517/14656566.5.8.1695] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
39 Patricia Léchot, Heinz J. Schaad, S. Group A Streptococcus Clones Causing Repeated Epidemics and Endemic Disease in Intravenous Drug Users. Scandinavian Journal of Infectious Diseases 2009;33:41-6. [DOI: 10.1080/003655401750064059] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
40 Kaneko M, Maruta M, Shikata H, Hanayama M, Ikebe T. Acute abdomen due to group A streptococcus bacteremia caused by an isolate with a mutation in the csrS gene. J Infect Chemother 2015;21:816-9. [PMID: 26231317 DOI: 10.1016/j.jiac.2015.06.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
41 McMillan DJ, Beiko RG, Geffers R, Buer J, Schouls LM, Vlaminckx BJ, Wannet WJ, Sriprakash KS, Chhatwal GS. Genes for the majority of group a streptococcal virulence factors and extracellular surface proteins do not confer an increased propensity to cause invasive disease. Clin Infect Dis 2006;43:884-91. [PMID: 16941370 DOI: 10.1086/507537] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 1.9] [Reference Citation Analysis]
42 Imöhl M, van der Linden M, Reinert RR, Ritter K. Invasive group A streptococcal disease and association with varicella in Germany, 1996–2009. FEMS Immunol Med Microbiol 2011;62:101-9. [DOI: 10.1111/j.1574-695x.2011.00788.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
43 Tang W, Ho P, Yau W, Wong J, Yip D. Report of 2 Fatal Cases of Adult Necrotizing Fasciitis and Toxic Shock Syndrome Caused by Streptococcus agalactiae. CLIN INFECT DIS 2000;31:e15-7. [DOI: 10.1086/318148] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
44 Shah AK, Kumar NB, Gambhir RP, Chaudhry R. Integrated clinical care pathway for managing necrotising soft tissue infections. Indian J Surg 2009;71:254-7. [PMID: 23133168 DOI: 10.1007/s12262-009-0076-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
45 Roth S, Andrassy K, Schmidt K, Günther E, Ritz E. Febrile lady with acute renal failure and desquamating erythema. American Journal of Kidney Diseases 1999;34:150-4. [DOI: 10.1016/s0272-6386(99)70122-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
46 Kim S, Yong Lee N. Antibiotic Resistance and Genotypic Characteristics of Group A Streptococci Associated with Acute Pharyngitis in Korea. Microbial Drug Resistance 2004;10:300-5. [DOI: 10.1089/mdr.2004.10.300] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
47 Moses AE, Goldberg S, Korenman Z, Ravins M, Hanski E, Shapiro M. Invasive group a streptococcal infections, Israel. Emerg Infect Dis 2002;8:421-6. [PMID: 11971778 DOI: 10.3201/eid0804.010278] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 1.7] [Reference Citation Analysis]
48 Das DK, Baker MG, Venugopal K. Increasing incidence of necrotizing fasciitis in New Zealand: a nationwide study over the period 1990 to 2006. J Infect 2011;63:429-33. [PMID: 21864570 DOI: 10.1016/j.jinf.2011.07.019] [Cited by in Crossref: 42] [Cited by in F6Publishing: 34] [Article Influence: 3.8] [Reference Citation Analysis]
49 Pichichero ME, Casey JR. Systematic review of factors contributing to penicillin treatment failure in Streptococcus pyogenes pharyngitis. Otolaryngol Head Neck Surg 2007;137:851-7. [DOI: 10.1016/j.otohns.2007.07.033] [Cited by in Crossref: 60] [Cited by in F6Publishing: 52] [Article Influence: 10.0] [Reference Citation Analysis]
50 Duane TM, Huston JM, Collom M, Beyer A, Parli S, Buckman S, Shapiro M, McDonald A, Diaz J, Tessier JM, Sanders J. Surgical Infection Society 2020 Updated Guidelines on the Management of Complicated Skin and Soft Tissue Infections. Surg Infect (Larchmt) 2021;22:383-99. [PMID: 33646051 DOI: 10.1089/sur.2020.436] [Reference Citation Analysis]
51 Imöhl M, Reinert RR, Ocklenburg C, van der Linden M. Epidemiology of invasive Streptococcus pyogenes disease in Germany during 2003-2007. FEMS Immunol Med Microbiol 2010;58:389-96. [PMID: 20146737 DOI: 10.1111/j.1574-695X.2010.00652.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
52 Carter PS, Banwell PE. Necrotising fasciitis: a new management algorithm based on clinical classification. Int Wound J 2004;1:189-98. [PMID: 16722877 DOI: 10.1111/j.1742-4801.2004.00054.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
53 Barbieri JT, Basma H, Norrby-teglund A, Guedez Y, Mcgeer A, Low DE, El-ahmedy O, Schwartz B, Kotb M. Risk Factors in the Pathogenesis of Invasive Group A Streptococcal Infections: Role of Protective Humoral Immunity. Infect Immun 1999;67:1871-7. [DOI: 10.1128/iai.67.4.1871-1877.1999] [Cited by in Crossref: 102] [Cited by in F6Publishing: 28] [Article Influence: 4.4] [Reference Citation Analysis]
54 Neeman R, Keller N, Barzilai A, Korenman Z, Sela S. Prevalence of internalisation-associated gene, prtF1, among persisting group-A streptococcus strains isolated from asymptomatic carriers. Lancet 1998;352:1974-7. [PMID: 9872247 DOI: 10.1016/S0140-6736(97)12452-7] [Cited by in Crossref: 105] [Cited by in F6Publishing: 39] [Article Influence: 4.6] [Reference Citation Analysis]
55 Liu HH. Antibiotic Resistance in Bacteria. In: Mallia C, Uitto J, editors. Rheumaderm. Boston: Springer US; 1999. pp. 387-96. [DOI: 10.1007/978-1-4615-4857-7_59] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
56 Daneman N, McGeer A, Low DE, Tyrrell G, Simor AE, McArthur M, Schwartz B, Jessamine P, Croxford R, Green KA; Ontario Group A Streptococcal Study Group. Hospital-acquired invasive group a streptococcal infections in Ontario, Canada, 1992-2000. Clin Infect Dis 2005;41:334-42. [PMID: 16007530 DOI: 10.1086/431589] [Cited by in Crossref: 31] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
57 McCormick JK, Tripp TJ, Olmsted SB, Matsuka YV, Gahr PJ, Ohlendorf DH, Schlievert PM. Development of streptococcal pyrogenic exotoxin C vaccine toxoids that are protective in the rabbit model of toxic shock syndrome. J Immunol 2000;165:2306-12. [PMID: 10925320 DOI: 10.4049/jimmunol.165.4.2306] [Cited by in Crossref: 46] [Cited by in F6Publishing: 33] [Article Influence: 2.1] [Reference Citation Analysis]
58 Salim KY, Cvitkovitch DG, Chang P, Bast DJ, Handfield M, Hillman JD, de Azavedo JC. Identification of group A Streptococcus antigenic determinants upregulated in vivo. Infect Immun 2005;73:6026-38. [PMID: 16113323 DOI: 10.1128/IAI.73.9.6026-6038.2005] [Cited by in Crossref: 31] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
59 Vlaminckx BJ, van Pelt W, Schouls LM, van Silfhout A, Mascini EM, Elzenaar CP, Fernandes T, Bosman A, Schellekens JF. Long-term surveillance of invasive group A streptococcal disease in The Netherlands, 1994-2003. Clin Microbiol Infect 2005;11:226-31. [PMID: 15715721 DOI: 10.1111/j.1469-0691.2004.01068.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
60 Vlaminckx BJ, van Pelt W, Schellekens JF. Epidemiological considerations following long-term surveillance of invasive group A streptococcal disease in The Netherlands, 1992-2003. Clin Microbiol Infect 2005;11:564-8. [PMID: 15966975 DOI: 10.1111/j.1469-0691.2005.01179.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
61 Morita JY, Kahn E, Thompson T, Laclaire L, Beall B, Gherardi G, O'brien KL, Schwartz B. Impact of azithromycin on oropharyngeal carriage of Group A Streptococcus and nasopharyngeal carriage of macrolide-resistant Streptococcus pneumoniae: . The Pediatric Infectious Disease Journal 2000;19:41-6. [DOI: 10.1097/00006454-200001000-00009] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 1.9] [Reference Citation Analysis]
62 Mcmillan DJ, Sriprakash KS, Chhatwal GS. Genetic variation in group A streptococci. International Journal of Medical Microbiology 2007;297:525-32. [DOI: 10.1016/j.ijmm.2007.02.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
63 Ho PL, Johnson DR, Yue AW, Tsang DN, Que TL, Beall B, Kaplan EL. Epidemiologic analysis of invasive and noninvasive group a streptococcal isolates in Hong Kong. J Clin Microbiol 2003;41:937-42. [PMID: 12624012 DOI: 10.1128/JCM.41.3.937-942.2003] [Cited by in Crossref: 42] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
64 Lau SK, Woo PC, Yim TC, To AP, Yuen KY. Molecular characterization of a strain of group a streptococcus isolated from a patient with a psoas abscess. J Clin Microbiol 2003;41:4888-91. [PMID: 14532252 DOI: 10.1128/JCM.41.10.4888-4891.2003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
65 Chatellier S, Ihendyane N, Kansal RG, Khambaty F, Basma H, Norrby-Teglund A, Low DE, McGeer A, Kotb M. Genetic relatedness and superantigen expression in group A streptococcus serotype M1 isolates from patients with severe and nonsevere invasive diseases. Infect Immun 2000;68:3523-34. [PMID: 10816507 DOI: 10.1128/IAI.68.6.3523-3534.2000] [Cited by in Crossref: 199] [Cited by in F6Publishing: 107] [Article Influence: 9.0] [Reference Citation Analysis]
66 Vlaminckx BJ, Schuren FH, Montijn RC, Caspers MP, Fluit AC, Wannet WJ, Schouls LM, Verhoef J, Jansen WT. Determination of the relationship between group A streptococcal genome content, M type, and toxic shock syndrome by a mixed genome microarray. Infect Immun 2007;75:2603-11. [PMID: 17325055 DOI: 10.1128/IAI.01291-06] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
67 Bessen DE, McShan WM, Nguyen SV, Shetty A, Agrawal S, Tettelin H. Molecular epidemiology and genomics of group A Streptococcus. Infect Genet Evol 2015;33:393-418. [PMID: 25460818 DOI: 10.1016/j.meegid.2014.10.011] [Cited by in Crossref: 47] [Cited by in F6Publishing: 34] [Article Influence: 5.9] [Reference Citation Analysis]
68 Patel RA, Binns HJ, Shulman ST. Reduction in pediatric hospitalizations for varicella-related invasive group a streptococcal infections in the varicella vaccine era. The Journal of Pediatrics 2004;144:68-74. [DOI: 10.1016/j.jpeds.2003.10.025] [Cited by in Crossref: 79] [Cited by in F6Publishing: 57] [Article Influence: 4.4] [Reference Citation Analysis]
69 Nyberg P, Sakai T, Cho KH, Caparon MG, Fässler R, Björck L. Interactions with fibronectin attenuate the virulence of Streptococcus pyogenes. EMBO J 2004;23:2166-74. [PMID: 15103329 DOI: 10.1038/sj.emboj.7600214] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 1.9] [Reference Citation Analysis]
70 Jing HB, Ning BA, Hao HJ, Zheng YL, Chang D, Jiang W, Jiang YQ. Epidemiological analysis of group A streptococci recovered from patients in China. J Med Microbiol 2006;55:1101-7. [PMID: 16849731 DOI: 10.1099/jmm.0.46243-0] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 2.1] [Reference Citation Analysis]
71 Minodier P, Laporte R, Miramont S. Épidémiologie des infections à streptocoque du groupe A dans les pays en développement. Archives de Pédiatrie 2014;21:S69-72. [DOI: 10.1016/s0929-693x(14)72263-8] [Cited by in Crossref: 6] [Article Influence: 0.8] [Reference Citation Analysis]
72 Rangaswamy M. Necrotizing fasciitis: a 10-year retrospective study of cases in a single university hospital in Oman. Acta Tropica 2001;80:169-75. [DOI: 10.1016/s0001-706x(01)00173-5] [Cited by in Crossref: 9] [Article Influence: 0.4] [Reference Citation Analysis]
73 Currie BJ, Carapetis JR. Skin infections and infestations in Aboriginal communities in northern Australia. Australas J Dermatol 2000;41:139-43; quiz 144-5. [PMID: 10954983 DOI: 10.1046/j.1440-0960.2000.00417.x] [Cited by in Crossref: 134] [Cited by in F6Publishing: 127] [Article Influence: 6.1] [Reference Citation Analysis]
74 Lin HC, Wang SM, Lin YL, Lin YS, Wu JJ, Chuang WJ, Lin MT, Liu CC. Group A streptococcal infection caused by emm1 strains among children in southern Taiwan. Eur J Clin Microbiol Infect Dis 2008;27:1253-6. [PMID: 18597127 DOI: 10.1007/s10096-008-0561-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
75 Bjorson GL, Scheifele DW, Bell A, King A. Population-based surveillance of invasive group A streptococcal disease in British Columbia: 1996 to 1998. Can J Infect Dis 2001;12:232-6. [PMID: 18159345 DOI: 10.1155/2001/270873] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
76 Barrozo CP, Russell KL, Smith TC, Hawksworth AW, Ryan MA, Gray GC. National Department of Defense surveillance data for antibiotic resistance and emm gene types of clinical group A streptococcal isolates from eight basic training military sites. J Clin Microbiol 2003;41:4808-11. [PMID: 14532227 DOI: 10.1128/JCM.41.10.4808-4811.2003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
77 Chen YY, Huang CT, Yao SM, Chang YC, Shen PW, Chou CY, Li SY. Molecular epidemiology of group A streptococcus causing scarlet fever in northern Taiwan, 2001-2002. Diagn Microbiol Infect Dis 2007;58:289-95. [PMID: 17532590 DOI: 10.1016/j.diagmicrobio.2007.01.013] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
78 Musser JM, Krause RM. 6 The revival of group A streptococcal diseases, with a commentary on staphylococcal toxic shock syndrome. Emerging Infections. Elsevier; 1998. pp. 185-218. [DOI: 10.1016/s1874-5326(07)80030-5] [Cited by in Crossref: 35] [Article Influence: 1.5] [Reference Citation Analysis]
79 Stevens DL. Dilemmas in the Treatment of Invasive Streptococcus pyogenes Infections. Clinical Infectious Diseases 2003;37:341-3. [DOI: 10.1086/376652] [Cited by in Crossref: 31] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
80 Koh EH, Lee NY, Kim EC, Kim S. Genetic diversity and exotoxin A production of group A streptococci causing sepsis. J Korean Med Sci 2006;21:193-8. [PMID: 16614500 DOI: 10.3346/jkms.2006.21.2.193] [Reference Citation Analysis]